bp retatrutide Guide 2023: Weight Loss, Benefits, Results, Dosage Retatrutide for Weight Loss: TRIUMPH-1

Higher doses of retatrutide produced significant weight loss, with Phase 2 trials reporting average reductions of about 24% of body weight after 48 weeks

Chavda V et al ., 2022

Med., vol

Patients who are on GLP-1 medications and stop them generally regain a substantial amount of the weight that they lost.

#DES #DES2026 #Diabetes #Orforglipron #DiabetesEducation #OralGLP1 #Endocrinology #DiabetesCare To view or add a comment, sign in **Is the Future of Obesity Treatment Moving from Injections to Pills?** For years, obesity management has been dominated by injectable GLP-1 receptor agonists such as semaglutide and tirzepatide

This provides optimism for greater individualized treatment moving forward